Multi-crosslinked photocurable hydrogel for dry eye therapy: dual ROS scavenging and macrophage reprogramming for mitochondrial redox homeostasis and inflammation regulation through HIF-1/NF-kappaB suppression

Asian J Pharm Sci. 2026 Oct;21(5):101209. doi: 10.1016/j.ajps.2026.101209. Epub 2026 Oct 18.

ABSTRACT

As air pollution intensifies and the use of electronic devices proliferates, the incidence of dry eye (DE) has surged, posing a significant burden on visual health. Given its complex pathogenesis and multifaceted etiology, achieving optimal therapeutic outcomes through a single treatment approach remains elusive. Hydrogel-based drug delivery systems have garnered considerable research attention. Here, a photocurable hydrogel (CsA@F127DA/DA-PEG-GelMA), that possesses both anti-inflammatory and antioxidant properties and utilizes advanced multi-crosslinking technology, was developed. This novel formulation significantly enhances the delivery efficiency of the hydrophobic immunosuppressant cyclosporine A (CsA). Furthermore, the incorporation of dopamine (DA) not only provides potent antioxidant and, ROS-scavenging capabilities, addressing ocular surface inflammatory disorders, but also endows the multifunctional hydrogel system with exceptional adhesion properties. The results showed that CsA@F127DA/DA-PEG-GelMA could not only inhibit the activation of NF-κB signaling pathway, regulate the polarization of macrophages and inhibit conjunctival inflammatory infiltration, but also inhibited the activation of HIF-1α signaling pathway, regulated glucose metabolism reprogramming, reduced the production of ROS, and thus maintained mitochondrial redox homeostasis. In summary, the dual inhibitory effect of CsA@F127DA/DA-PEG-GelMA on inflammation and oxidative stress effectively ameliorated the vicious cycle of DE, increased tear secretion, and significantly alleviated DE symptoms.

PMID:43032005 | PMC:PMC13760072 | DOI:10.1016/j.ajps.2026.101209